Hugh M. Davis

Insider Reports History

Location
Wayne, PA
Signature
/s/ Matthew Rothman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hugh M. Davis:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aclaris Therapeutics, Inc. President and COO, Director Restricted Stock Units 56,025 $185,256 $2.48 03 Feb 2026 Direct
Aclaris Therapeutics, Inc. President and COO, Director Common Stock 45,425 $136,688 $3.01 03 Feb 2026 Direct
Aclaris Therapeutics, Inc. President and COO, Director Employee Stock Option (Right to Buy) 336,300 02 Feb 2026 Direct

Insider Reports Filed by Hugh M. Davis

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ACRS Aclaris Therapeutics, Inc. 03 Feb 2026 2 $0 4 President and COO, Director 05 Feb 2026, 16:44
ACRS Aclaris Therapeutics, Inc. 02 Feb 2026 2 $0 4 President and COO, Director 06 Feb 2026, 18:08
ACRS Aclaris Therapeutics, Inc. 02 Dec 2025 2 $0 4 President and COO, Director 04 Dec 2025, 16:50
ACRS Aclaris Therapeutics, Inc. 03 Feb 2025 2 $0 4 President and COO, Director 04 Feb 2025, 16:15
ACRS Aclaris Therapeutics, Inc. 02 Dec 2024 2 $0 4 President and COO, Director 03 Dec 2024, 17:42
ACRS Aclaris Therapeutics, Inc. 18 Nov 2024 0 $0 3 President and COO, Director 18 Nov 2024, 16:20